Abstract
The purpose of this study was to examine the long-term outcome of Stage I large-cell non-Hodgkin's lymphoma patients treated with primary radiotherapy and to assess the potential influence of these results on the development of future treatment protocols for non-Hodgkin's lymphoma. Between April 1970 and July 1983, 15 pathological Stage I and four pathological Stage II large cell lymphoma patients were treated with primary radiotherapy at the University of Minnesota Hospital and Clinics. This paper focuses on the long-term outcome of the 15 Stage I patients. As of March 1995, with a median survival of 171 months, five of the 15 Stage I patients are alive: four with no sign of lymphoma and one with recurrence and a secondary malignant neoplasm (SMN). Estimated 5- and 10- year recurrence-free survival rates are 86% and 78%, respectively. Overall survival at 5 years is 80% and at 10 years, 67%. Six patients developed SMNs, all of which were solid tumors. Ten of the 15 patients died: four from SMNs, three from non-Hodgkin's lymphoma, and three from other causes without recurrence (two died of cardiovascular disease and one of a pulmonary embolism). Deaths due to lymphoma in pathologic Stage I patients treated by radiotherapy alone ...Continue Reading
References
Sep 1, 1979·Cancer·T G LandbergO G Dahl
Apr 1, 1979·Cancer·M G ChenD B Fischer
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J K WeickH I Pierce
May 1, 1991·Hematological Oncology·M LishnerS Sutcliffe
Mar 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G CiminoD Giannarelli
Apr 1, 1991·Cancer·L B TravisJ F Fraumeni
Jan 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M CossetM Tubiana
May 1, 1985·Cancer·R T Hoppe
Jan 1, 1985·Hematological Oncology·F Cabanillas
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesJ M Connors
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Sep 1, 1988·International Journal of Radiation Oncology, Biology, Physics·B R PrestidgeR T Hoppe
Jun 15, 1988·Cancer·J F Boivin, K O'Brien
Jan 14, 1988·The New England Journal of Medicine·M A TuckerS A Rosenberg
Jun 1, 1986·Annals of Internal Medicine·M S KaminskiS A Rosenberg
Jan 1, 1985·Hematological Oncology·S H LevittG Frizzera
Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E E VokesD Oleske
Nov 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S B SutcliffeM V Peters
Sep 1, 1973·Cancer·S E JonesS A Rosenberg
Feb 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A T SkarinE Frei
Sep 15, 1983·Cancer·J Albores-SaavedraD E Henson
Jul 1, 1983·Cancer·N I NissenJ Rygård
Feb 1, 1980·International Journal of Radiation Oncology, Biology, Physics·S MonfardiniA Lattuada